Technical / White Paper
Selecting a dosage form for delivery to the lungs
Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required dose, the target patient population, timeline and budget are all important considerations.
Other factors, such as biopharmaceutics, intellectual property, marketing and the competitive landscape, may also be relevant. Download Recipharm’s free inhalation whitepaper here for all you need to know when selecting an appropriate dosage form for drug delivery to the lungs.
